NCT04040673Withdrawn
RAman For Thyroid cancER
Evaluation of the Role of Vibrational Spectroscopy in the Diagnosis of Premalignant and Malignant Disease of the Thyroid RAFTER (RAman For Thyroid cancER)
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Reason given: Covid19 halted study
Brief summary (registry, in English)
Ex vivo vibrational spectroscopy (VS), including Raman spectroscopy (RS) of thyroid tissue samples, collected from patients undergoing routine diagnostic thyroid biopsies for diagnosis of potential thyroid cancer. Raman spectra are to be correlated with consensus histopathology and clinical outcomes. Multivariate analysis to be used to evaluate the classification accuracy of VS ex vivo.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 29 Jul 2019
- Start date
- 31 Jan 2024
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Gloucestershire Hospitals NHS Foundation Trust
- Diseases
- Thyroid cancer
- NCT number
- NCT04040673
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients not attending for standard diagnostic biopsy for thyroid cancer
Other
- Patients are unable to provide informed consent.
Who the study is looking for
- Patients undergoing routine diagnostic thyroid biopsy at surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Biophotonics Research Unit | Gloucester | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.